Company Filing History:
Years Active: 2025
Title: Dena Demarco: Innovator in Bispecific Antibodies
Introduction
Dena Demarco is a prominent inventor based in Chatham, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. Her work focuses on innovative treatments for diseases, showcasing her dedication to advancing medical science.
Latest Patents
Dena Demarco holds a patent for bispecific antibodies against CD3 and CD20. This invention relates to bispecific antibodies (bsAbs) and their application in treating diseases in subjects. The patent outlines advantageous treatment regimens for B-cell Non-Hodgkin Lymphoma (B-NHL), highlighting the potential impact of her work on cancer therapies.
Career Highlights
Throughout her career, Dena has been associated with Genmab A/S, a leading biotechnology company. Her role at Genmab has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to medical research.
Collaborations
Dena has worked alongside notable colleagues such as Tahamtan Ahmadi and Manish Gupta. These collaborations have fostered an environment of innovation and shared knowledge, driving advancements in their respective areas of expertise.
Conclusion
Dena Demarco's work in bispecific antibodies represents a significant advancement in the treatment of B-cell Non-Hodgkin Lymphoma. Her innovative spirit and dedication to research continue to inspire progress in the field of biotechnology.